DUSP11 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.037000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.603400E-01
Normal-vs-Stage2
7.402400E-01
Normal-vs-Stage3
3.477400E-01
Normal-vs-Stage4
2.634600E-01
Stage1-vs-Stage2
4.691400E-01
Stage1-vs-Stage3
7.342800E-01
Stage1-vs-Stage4
5.674000E-02
Stage2-vs-Stage3
3.131600E-01
Stage2-vs-Stage4
4.060000E-02
Stage3-vs-Stage4
9.537700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.787600E-01
Normal-vs-AfricanAmerican
7.675000E-01
Normal-vs-Asian
7.131400E-01
Caucasian-vs-AfricanAmerican
8.531200E-01
Caucasian-vs-Asian
8.754600E-01
AfricanAmerican-vs-Asian
8.330800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.491200E-01
Normal-vs-Female
7.821600E-01
Male-vs-Female
4.116600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.106400E-01
Normal-vs-Age(41-60Yrs)
9.375400E-01
Normal-vs-Age(61-80Yrs)
5.747200E-01
Normal-vs-Age(81-100Yrs)
5.316600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.887400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.589600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.766800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.110100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.870000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.659000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.557000E-01
Normal-vs-Daily Drinker
6.079600E-01
Normal-vs-Weekly Drinker
4.112400E-01
Normal-vs-Occasional Drinker
6.131200E-01
Normal-vs-Social Drinker
5.455800E-01
Non Drinker-vs-Daily Drinker
9.915200E-01
Non Drinker-vs-Weekly Drinker
6.357600E-01
Non Drinker-vs-Occasional Drinker
3.908000E-02
Non Drinker-vs-Social Drinker
7.226600E-01
Daily Drinker-vs-Weekly Drinker
6.712400E-01
Daily Drinker-vs-Occasional Drinker
7.036400E-02
Daily Drinker-vs-Social Drinker
7.394200E-01
Weekly Drinker-vs-Occasional Drinker
2.459800E-02
Weekly Drinker-vs-Social Drinker
4.188800E-01
Occasional Drinker-vs-Social Drinker
6.620400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.441620E-01
Normal-vs-Grade 2
3.182600E-03
Normal-vs-Grade 3
9.996100E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.197550E-02
Grade 1-vs-Grade 3
8.661000E-03
Grade 1-vs-Grade 4
1.441620E-01
Grade 2-vs-Grade 3
7.025400E-01
Grade 2-vs-Grade 4
3.182600E-03
Grade 3-vs-Grade 4
9.996100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.340400E-01
Normal-vs-NonDiabetic
6.582600E-01
Diabetic-vs-NonDiabetic
4.585800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.227800E-01
Normal-vs-NoPancreatitis
6.900800E-01
Pancreatitis-vs-NoPancreatitis
4.047400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.404600E-01
Normal-vs-N1
7.647200E-01
N0-vs-N1
6.317400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.985800E-01
Normal-vs-TP53-NonMutant
4.555800E-01
TP53-Mutant-vs-TP53-NonMutant
1.001540E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
